mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.03 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.04 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.04 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |